A Phase III Trial on Adjuvant Standard Temozolomide Chemotherapy With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Interferon alpha (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 21 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 10 Dec 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 24 Jan 2013 New trial record